Peervoice Program 2026

Turning Pathophysiologic Promise into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?

The Rationale for Revisiting Our Approach to Secondary Stroke Prevention - and Why Factor XIa Inhibition Factors In: Let's Put the Experts to the Test

Duration: 20 min

Release: February 27, 2026

Available at: https://ime2.peervoice.com/140202549_2/140202549_2_p1-en/screen0?Language=en&MemberID=324289157&CountryID=US

^{This activity is supported by an educational grant from Bayer AG. Bayer AG has had no involvement in the selection of speakers, the development of this activity, the agenda or the materials.}

^{This presentation may contain information regarding investigational products for which market authorization has not been obtained from Health Canada.}

^{MA-M_ASUN-CA-0018-1}